SUBSCRIBE
SUBSCRIBE

bioAffinity Technologies, Inc.

IN THE PRESS
Business
bioAffinity Technologies Reports Second Quarter 2023 Financial Results and Provides Business Update
August 14, 2023
 · 
10 min read
Lone Star Bio
AMA Issues CPT Code for bioAffinity Technologies’ CyPath® Lung Test for Early-Stage Lung Cancer
July 12, 2023
 · 
5 min read
Lone Star Bio
bioAffinity Technologies Presents Research Findings at UMass RNA Therapeutics Symposium
June 15, 2023
 · 
4 min read
Lone Star Bio
bioAffinity Technologies Presents Research Findings at CYTO 2023
May 22, 2023
 · 
3 min read
Business
bioAffinity Technologies Reports First Quarter 2023 Financial Results
May 15, 2023
 · 
8 min read
Business
bioAffinity Technologies Names Michael Dougherty as Chief Financial Officer
May 1, 2023
 · 
3 min read
Biotech Beach
bioAffinity Technologies Presents at Cleveland Clinic Lung Cancer Symposium
April 25, 2023
 · 
3 min read
Business
bioAffinity Technologies Reports Fourth Quarter and Full Year 2022 Financial Results
March 31, 2023
 · 
10 min read
Biotech Beach
bioAffinity Technologies Announces Publication of Peer-Reviewed Paper on Proprietary Beads Used in CyPath® Lung for Noninvasive Detection of Early-Stage Lung Cancer
March 28, 2023
 · 
3 min read
Business
bioAffinity Technologies to Report Fourth Quarter 2022 Financial Results on March 31, 2023
March 24, 2023
 · 
2 min read
Load More
JOBS